Infliximab use in Crohn's disease: impact on health care resources in the UK.

Infliximab use in Crohn's disease: impact on health care resources in the UK.

OBJECTIVE: To quantify the impact of infliximab therapy on health care resource utilization in the UK. METHODS: A retrospective audit was undertaken at seven centres in the UK, which reviewed patient notes for a period of 6 months before and 6 months after an initial infliximab infusion. Details of...

Detaylı Bibliyografya
Asıl Yazarlar:	Jewell, D, Satsangi, J, Lobo, A, Probert, C, Forbes, A, Ghosh, S, Shaffer, J, Frenz, M, Drummond, H, Troy, G, Turner, S, Younge, L, Evans, L, Moosa, M, Rodgers-Gray, B, Buchan, S
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2005

Benzer Materyaller

Infliximab in Crohn's disease
Yazar:: L. Rodrigo Sáez

Infliximab in the Treatment of Crohn’s Disease
Yazar:: Brian Feagan
Baskı/Yayın Bilgisi: (2000-01-01)

Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
Yazar:: Hyder, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Molecular genetics of Crohn's disease: recent advances.
Yazar:: Satsangi, J, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Predictors of response to infliximab in patients with fistulizing Crohn's disease Factores predictivos de respuesta a infliximab en pacientes con enfermedad de Crohn fistulizante
Yazar:: M. Luna-Chadid, ve diğerleri
Baskı/Yayın Bilgisi: (2004-06-01)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
Yazar:: Luis Eduardo Miani Gomes, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Tratamento da doença de Crohn com infliximabe: primeira opção? Treatment of Crohn's disease with infliximab: first choice?
Yazar:: Anna Paula Rocha Malheiros, ve diğerleri
Baskı/Yayın Bilgisi: (2009-06-01)

Profile of infliximab in the treatment of pediatric Crohn’s disease
Yazar:: Kierus J, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
Yazar:: Diana Carvalho, ve diğerleri
Baskı/Yayın Bilgisi: (2017-09-01)

Comparison between prospective and retrospective evaluation of Crohn's disease activity index.
Yazar:: Frenz, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Crohn’s disease or Crohn’s diseases?
Yazar:: Arnott, IDR, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Infliximab for ulcerative colitis.
Yazar:: Simmons, J, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Azathioprine and Infliximab: Monotherapy or Combination Therapy in the Treatment of Crohn's Disease
Yazar:: Bryan L. Love, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Demyelination-Like Syndrome In Crohn’s Disease After Infliximab Therapy
Yazar:: Hugh J Freeman, ve diğerleri
Baskı/Yayın Bilgisi: (2005-01-01)

Infliximab for Crohn's Disease: More Questions than Answers
Yazar:: Hugh James Freeman
Baskı/Yayın Bilgisi: (2001-01-01)

Listeria Meningitis Complicating Infliximab Treatment for Crohn’s Disease
Yazar:: Geoffrey Williams, ve diğerleri
Baskı/Yayın Bilgisi: (2005-01-01)

Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
Yazar:: Aibar Aginbay, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Infliximab-induced psoriasis in a patient with crohn′s disease
Yazar:: Iqbal Bukhari, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
Yazar:: You Lim Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Infliximab-induced intertriginous psoriasis in patient with Crohn's desease
Yazar:: Federica Mola, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

Intestinal fibrosis is associated with lack of response to Infliximab therapy in Crohn's disease.
Yazar:: Jessica R de Bruyn, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy.
Yazar:: Wilhelmina M C Timmermans, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.
Yazar:: Dario Sorrentino, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
Yazar:: Clark, W, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
Yazar:: Clark, W, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
Yazar:: Clark, W, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
Yazar:: W. Clark, ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
Yazar:: Neeraj Narula, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn’s Disease
Yazar:: Saeed Razmeh, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

The impact of medication belief on adherence to infliximab in patients with Crohn’s disease
Yazar:: Shuyan Li, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Early intestinal obstruction after infliximab therapy in Crohn’s disease
Yazar:: Mitsuro Chiba, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

Closure of enterovesical fistula in Crohn’s disease with infliximab: case report
Yazar:: Flávio Steinwurz
Baskı/Yayın Bilgisi: (2003-03-01)

Response to Infliximab in Crohn’s Disease: Genetic Analysis Supporting Expression Profile
Yazar:: Luz María Medrano, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn’s disease stopping infliximab
Yazar:: Pierre, N, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn’s disease
Yazar:: Zhang M, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes?
Yazar:: De Silva, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
Yazar:: E.N. Fedulova, ve diğerleri
Baskı/Yayın Bilgisi: (2009-08-01)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
Yazar:: E.N. Fedulova, ve diğerleri
Baskı/Yayın Bilgisi: (2009-08-01)

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
Yazar:: Tadakazu Hisamatsu, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Pulmonary Mucormycosis in a Patient with Crohn Disease on Immunosuppressive Medications including Infliximab
Yazar:: Alissa J Wright, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)